ImmunoGen, Inc. Announces Webcast of Presentation at the 12th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN) is scheduled to present at the 12th Annual BIO CEO & Investor Conference at 2:30 pm ET on February 9, 2010. The Conference is being held at the Waldorf=Astoria hotel in New York City. ImmunoGen’s presentation will be webcast live and can be accessed through the “Investor Information” section of our website, www.immunogen.com. An archive of the webcast will be available at the same location until February 14, 2010.
MORE ON THIS TOPIC